David O'Brien Email

Head Market Insight & Commercial Analytics . Avadel Pharmaceuticals plc

Current Roles

Employees:
223
Revenue:
$34.6M
About
Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead drug candidate, FT218, is an investigational formulation of sodium oxybate leveraging our proprietary drug delivery technology and designed to be taken once at bedtime for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. At Avadel, our core values foster an atmosphere of innovation and collaboration. In everything we do, we consider the patient experience, listening to their needs as we pursue the development and delivery of medicines that will transform the treatment landscape and have the greatest impact on people living with narcolepsy. Learn more about us at www.avadel.com and follow us on Twitter at @AvadelPharma.
Avadel Pharmaceuticals plc Address
16640 Chesterfield Grove Road
Dublin, null
IRE
Avadel Pharmaceuticals plc Email
Avadel Pharmaceuticals plc Phone Numbers
636-449-1830

Past Companies

Avadel Pharmaceuticals plcHead of Market Insight & Commercial Analytics
Biogen IdecDirector, Customer & Market Insight
BiogenSr. Director Global Customer & Market Insights

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.